US 6962933
Method for inhibiting p38 MAP kinase or TNF-α production using a 1,3-thiazole
expired A61KA61K31/4439A61K31/444
Quick answer
US patent 6962933 (Method for inhibiting p38 MAP kinase or TNF-α production using a 1,3-thiazole) held by Takeda Pharmaceutical Company Limited expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4439, A61K31/444, A61P, A61P1/04